{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-028949","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2025-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.768783+00:00","generated_at":"2026-05-17T06:45:14.965678+00:00","sec_items":["2.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"NRx subsidiary HOPE Therapeutics completes acquisition of Dura Medical","bullets":["Dura Medical is revenue generating and EBITDA positive; operates clinics in Naples and Ft. Myers.","Offers ketamine therapy, TMS, Spravato, stellate ganglion blocks for depression and PTSD.","Participates in VA Community Cares Network; founder Stephen Durand appointed Director of Florida Clinic Operations.","Combined with pending acquisitions to provide coverage at more than 8 locations on Florida's West Coast."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-028949","json":"https://secwatch.observer/filing/0001437749-25-028949.json","markdown":"https://secwatch.observer/filing/0001437749-25-028949.md","text":"https://secwatch.observer/filing/0001437749-25-028949.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000143774925028949/0001437749-25-028949-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000143774925028949/nrxp20250912_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:45:14.965678+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6c9bd154063c8efdea604b7f0444938f4cdae4e5","claim":"NRX Pharmaceuticals, Inc. completed an acquisition involving Dura Medical, LLC for a combination of cash, membership interests in HTX Management Company LLC (which are convertible into shares of Hope Therapeutics on a one-for-one basis at the (closed 2025-09-08).","evidence_excerpt":"On September 8, 2025, NRx Pharmaceuticals (NASDAQ: NRXP, or the “Company”), principally through its subsidiary HOPE Therapeutics, Inc., a Delaware corporation, completed its previously announced acquisition of Dura Medical, LLC","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1719406/000143774925028949/0001437749-25-028949-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Dura Medical, LLC"},{"label":"Consideration","value":"a combination of cash, membership interests in HTX Management Company LLC (which are convertible into shares of Hope Therapeutics on a one-for-one basis at the"},{"label":"Closing","value":"2025-09-08"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}